Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06133140 · ClinicalTrials.gov registry record
Continuous Ward Monitoring With the GE Portrait Mobile Monitoring Solution: the COSMOS Trial
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 227
- Enrollment target
NCT06133140: Completed study, sponsored by The Cleveland Clinic.
NCT06133140 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 227 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06133140 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 227 participants
- Enrollment target
Study Summary
The investigators plan to determine whether unblinded continuous ward monitoring with the GE Portrait Mobile Monitoring Solution and nursing alerts reduces vital sign abnormalities in patients recovering from major noncardiac surgery.
Primary Outcome
Area of oxygen saturation defined as SpO2 ≤85%.
Interventions
- DEVICE Unblinded postoperative vital sign monitoring
- DEVICE Blinded postoperative vital sign monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 227 participants |
| Start Date | 2024-02-14 |
| Est. Completion | 2026-01-06 |
What the finished NCT06133140 record still lists
NCT06133140 is an observational study that tracks outcomes without assigning an intervention. The registered 227 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Unblinded postoperative vital sign monitoring is the first listed.
NCT06133140 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06133140 about?
NCT06133140 is a clinical study titled "Continuous Ward Monitoring With the GE Portrait Mobile Monitoring Solution: the COSMOS Trial". The investigators plan to determine whether unblinded continuous ward monitoring with the GE Portrait Mobile Monitoring Solution and nursing alerts reduces vital sign abnormalities in patients recovering from major noncardiac surgery.
What is the current status of trial NCT06133140?
This trial is currently completed. The enrollment target is 227 participants. The study started on 2024-02-14. Estimated completion is 2026-01-06.
What interventions are being tested in trial NCT06133140?
The interventions under investigation include: Unblinded postoperative vital sign monitoring (DEVICE), Blinded postoperative vital sign monitoring (DEVICE).
Who is sponsoring clinical trial NCT06133140?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04751409 · 227 participants · Phase 2
Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities
- NCT05742360 · 227 participants
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
- NCT05890352 · 227 participants · Phase 2
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
- NCT05107908 · 228 participants · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI